Ultrasound training simulator developer MedSim of Kfar-Sava, Israel, and contrast agent firm Sonus Pharmaceuticals of Bothell, WA, have agreed to jointly develop a training program that will help physicians learn to use ultrasound contrast more
Ultrasound training simulator developer MedSim of Kfar-Sava, Israel, and contrast agent firm Sonus Pharmaceuticals of Bothell, WA, have agreed to jointly develop a training program that will help physicians learn to use ultrasound contrast more effectively. The two companies are planning to develop a contrast module that will run on MedSim's UltraSim ultrasound training simulator (SCAN Special Report 4/97).
UltraSim enables users to conduct virtual ultrasound exams by scanning a mannequin and accessing ultrasound data stored on CD-ROM that correspond to the area being examined. Sonus hopes an UltraSim contrast module will help the company train large numbers of physicians in the use of its EchoGen contrast agent for echocardiography. The companies plan to conduct a feasibility study on the module at a major U.S. ultrasound teaching institution.
Could Virtual Non-Contrast Images from Photon-Counting CT Reduce Radiation Dosing with CCTA?
March 28th 2024Emerging research on coronary artery calcium scoring for the assessment of coronary artery disease (CAD) suggests the use of virtual non-contrast images from photon-counting CT may lead to a nearly 20 percent reduction in radiation dosing.
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.